Tehran University of Medical Sciences

Science Communicator Platform

Share By
Dysregulation of the Immune Response in Coronavirus Disease 2019 Publisher Pubmed



Mohamed Khosroshahi L1 ; Rezaei N1, 2, 3
Authors

Source: Cell Biology International Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can trigger a cytokine storm in the pulmonary tissue by releasing various types of mediators, leading to acute respiratory distress syndrome (ARDS). Increased neutrophil-to-lymphocyte ratio, as well as CD4+ T lymphopenia, is reported in cases with novel coronavirus disease (COVID-19), meanwhile, lymphopenia is a significant finding in the majority of COVID-19 cases with a severe phenotype. Moreover, excessive activation of monocyte/macrophage and cytokine storms are associated with the severity of the disease and the related complications in SARS-CoV-2 infection. Understanding the immune response dysregulation in COVID-19 is essential to develop more effective diagnostic, therapeutic, and prophylactic strategies in this pandemic. © 2020 International Federation for Cell Biology
Other Related Docs
4. Lymphopenia in Covid-19: Therapeutic Opportunities, Cell Biology International (2020)
12. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
15. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
18. Cytokines and Covid-19: Friends or Foes?, Human Vaccines and Immunotherapeutics (2020)